Delivery Order SPE2DB22D1017-SPE2DB25FG1LN
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $14,356.96 and a period of performance through April 16, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $10,209.05 and is a firm fixed-price delivery order, with an ultimate completion date of April 29, 2025. The contract is not set aside and is open to full and open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price and a ceiling value of $8,761.71. It was awarded on April 16, 2025, with an ultimate completion date of April 17, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price of $3,795.27 and a completion date of April 23, 2025. This award is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $12,154.60. It is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $3,572.77 and a period of performance through April 8, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price and a ceiling value of $11,714.10. It is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of April 30, 2025...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $12,557.35 and a performance period ending on April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Myrbetriq ER 50 mg tablets, a medication used for the treatment of overactive bladder. The contract has a firm fixed-price, $34,152.51 ceiling value, and an ultimate completion date of February 21, 2024. This contract award is not associated with a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a pharmaceutical product used for the treatment of overactive bladder. The contract has a ceiling value of $4,816.17 and runs until February 10, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...